Cuts are expected to result in monthly cash savings of about $400,000.
$12 million of biological assets and about $65 million of inventory not authorized by CannTrust’s licence.
Follows Health Canada’s suspension of pot company’s licences to produce and sell pot.
Pot products producer’s authority to produce and sell cannabis had been suspended.
Regulator found problems at the company’s greenhouse in Pelham and later raised issues regarding the Vaughan manufacturing facility.
Cannabis company waiting on timing and impact of Health Canada’s decisions regarding non-compliance with regulatory requirements.
Decision based on an inspection in July following revelations a greenhouse in Pelham was non-compliant.
RCMP is investigating issues around unlicensed growing at CannTrust’s greenhouse.